PRKDC and cancer: We are the first to comprehensively describe that PRKDC mutations, regardless of the status of other DDR‐related genes, and found an association with an increased TMB, an increased mRNA expression of immune‐related genes, and a superior response to ICI in pan‐cancer patients.